🟢 Medpace Holdings is trading 46% up in pre-market with no company-specific catalyst identified

Medpace Holdings is trading 45.88% up at $848.93 in pre-market after no company-specific announcement dated August 14, 2026 was identified.

• Recent coverage points to the July 22 second-quarter earnings beat and raised 2026 guidance, which were already reported and do not clearly explain the move.
• Broader indexes are essentially flat, making a market-wide catalyst unlikely.
• The move may warrant rechecking for delayed or unreported news.